Unaudited Standalone Financial Results of the Company for the Quarter and half Year Ended on 30th September, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Adline Chem Lab Ltd reported weak unaudited results for Q2/H1 FY26. Total income stood at just ₹24.99 lakhs for H1 FY26 (with no revenue in the comparable prior periods shown), against total expenses of about ₹13.89 lakhs. The company posted a loss before tax of ₹13.89 lakhs for H1 FY26 and a loss after tax of ₹12.21 lakhs, widening from the prior half year. The balance sheet is deeply stressed: other equity is negative at ₹(746.41) lakhs versus share capital of ₹585 lakhs, putting net worth at roughly ₹(161) lakhs, with non-current borrowings of ₹164.95 lakhs. Operating cash flow was negative at ₹(9.50) lakhs for the half year. The statutory auditor (Jain Kedia & Sharma) issued an unmodified limited review report. Separately, Managing Director Sarang Pathak and Non-Executive Director Hemant Parikh resigned with effect from close of business on November 12, 2025, and Vrushank Patel was appointed as the new Chairman.
This is a negative filing for shareholders — the company continues to report losses, is operating with negative net worth and persistent cash burn, and now faces a top-level leadership transition. The stock is likely to remain under pressure, and small investors should weigh the going-concern-type risk profile carefully.